Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sustained Virological Response”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01225380
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Infection
Gilead Sciences 324
Post-approval studies (Phase 4)Study completedNCT00470210
What this trial is testing

Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens

Who this might be right for
Hepatitis CHIV Infections
Germans Trias i Pujol Hospital 10
Not applicableStudy completedNCT03002818
What this trial is testing

Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)

Who this might be right for
Chronic Hepatitis C Virus (HCV)
AbbVie 41
Large-scale testing (Phase 3)UnknownNCT03236610
What this trial is testing

Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Entecavir Plus Tenofovir

Who this might be right for
Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48
Uijeongbu St. Mary Hospital 112
Not applicableStudy completedNCT01070550
What this trial is testing

PROPHESYS 1: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Virus (HCV)Treated With Pegasys (Peginterferon Alfa-2a)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 4,680
Testing effectiveness (Phase 2)Study completedNCT01482403
What this trial is testing

Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 58
Large-scale testing (Phase 3)UnknownNCT03236584
What this trial is testing

Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus Adefovir

Who this might be right for
Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48
Uijeongbu St. Mary Hospital 76
Not applicableStudy completedNCT01066819
What this trial is testing

PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,656
Large-scale testing (Phase 3)Ended earlyNCT02455167
What this trial is testing

Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis

Who this might be right for
Hepatitis C
University of Colorado, Denver 9
Not applicableUnknownNCT04732832
What this trial is testing

HCV Reinfection in HD Patients Achieving SVR

Who this might be right for
Hepatitis C Virus InfectionHepatitis C Virus Infection, Response to Therapy ofHemodialysis Complication
National Taiwan University Hospital 350
Not applicableUnknownNCT02581033
What this trial is testing

Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B.
St Vincent's Hospital Melbourne 200
Not applicableStudy completedNCT02725866
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 216
Not applicableStudy completedNCT03453346
What this trial is testing

Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C

Who this might be right for
Hepatitis C, ChronicHepatitis C Virus Infection, Response to Therapy of
Kawin Technology Share-holding Co., Ltd. 136
Post-approval studies (Phase 4)Study completedNCT00724620
What this trial is testing

PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Schering-Plough 103
Not applicableNot Yet RecruitingNCT07097870
What this trial is testing

Predictors of HCC in Post-HCV Cirrhotic Patients After SVR

Who this might be right for
HCC - Hepatocellular Carcinoma
Sohag University 400
Testing effectiveness (Phase 2)Study completedNCT00919633
What this trial is testing

Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C

Who this might be right for
Hepatitis C
Medtronic Corporate Technologies and New Ventures 116
Not applicableStudy completedNCT01066793
What this trial is testing

PROPHESYS 2: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 2,343
Large-scale testing (Phase 3)Study completedNCT02966795
What this trial is testing

Of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 84
Post-approval studies (Phase 4)Study completedNCT01447420
What this trial is testing

Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 129
Testing effectiveness (Phase 2)Study completedNCT00517439
What this trial is testing

Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 516
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation